Danazol for paroxysmal nocturnal hemoglobinuria

American Journal of Hematology

Volumn 54, Issue 2, 1997, Pages 149-154

  Harrington Sr , William J ^a   Kolodny, Luciano ^a   Horstman, Lawrence L ^a   Jy, Wenche ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

androgen therapy; danazol; PNH

Indexed keywords

DANAZOL; FLUOXYMESTERONE; GLUCOCORTICOID;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HEMATOCRIT; HEMOLYSIS; HUMAN; MALE; PANCYTOPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CIRCADIAN RHYTHM; DANAZOL; FEMALE; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION;

EID: 1842368532     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199702)54:2<149::AID-AJH9>3.0.CO;2-X     Document Type: Article

References (31)

1. Dacie JV: Paroxysmal nocturnal hemoglobinuria. In Dacie JV (ed): "The Hemolytic Anemias, Part IV." New York: Grune and Stratton, Inc., 1967.
2. Rotoli B, Luzzatto L: Paroxysmal nocturnal hemoglobinuria. Semin Hematol 26:201, 1989.
3. Morgan BP, Men S: Membrane proteins that protect against complement lysis. Springer Semin Immunopathol 15:369, 1994.
4. Parker CJ: Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement. Clin Exp Immunol 86:36, 1991.
5. Rosse WF, Ware RE: The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 86:3277, 1995.
6. Rosse WF: Treatment of paroxysmal nocturnal hemoglobinuria. Blood 60:20, 1982.
7. Issaragrisil S, Piankijagum A, Tang-Naitrisorana Y: Corticosteroids therapy in paroxysmal nocturnal hemoglobinuria. Am J Hematol 25:77, 1987.
8. Hartmann RC, Jenkins DE Jr, McKee LC, Heyssel RM: Paroxysmal nocturnal hemoglobinuria: Clinical and laboratory studies relating to iron metabolism and therapy with androgen and iron. Medicine (Baltimore) 45:331, 1966.
9. Gomperts ED, Zail SS, Christensen D: The effect of vitamin E on haemolysis in paroxysmal nocturnal haemoglobinuria: In vitro and in vivo studies. Scand J Haematol 14:81, 1975.
10. Stabler C, Tichelli A, Dazzi H, et al.: High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: A pilot study. Exp Hematol 18:1204, 1990.
11. Fefer A, Freeman H, Storb R, et al,: Paroxysmal nocturnal hemoglobinuria and marrow failure treated by infusion of marrow from an identical twin. Ann Intern Med 84:692. 1976.
12. Antin JH, Ginsburg D, Smith BR: Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: Eradication of the pnh clone and documentation of complete lymphohematopoietic engraftment. Blood 66:1247, 1985.
13. Hillmen P, Lewis SM, Bressler M, et al.: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333:1253, 1995.
14. Barbieri RL, Ryan KJ: Danazol: Endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol 141:453, 1981.
15. Gelfand JA, Sherins RJ, Alling DW, Frank MM: Treatment of hereditary angioedema with danazol: Reversal of clinical and biochemical abnormalities. N Engl J Med 295:1444, 1976.
16. Ahn YS, Harrington WJ, Simon SR, et al.: Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 308:1396, 1983.
17. Ahn YS, Harrington WJ, Mylvaganam R, et al.: Danazol therapy for autoimmune hemolytic anemia. Ann Intern Med 102:298, 1985.
18. Ahn YS: Efficacy of danazol in hematologic disorders. Acta Haematol (Basel) 84:122, 1990.
19. Hurrington WJ, Ahn YS, Cohen L, et al.: Treatment of paroxysmal nocturnal hemoglobinuria with danazol. Presented at Amer Soc Hemat Mtg, December 1984. Blood 64:253, 1984.
20. Buamah P: An apparent danazol-induced primary hepatocellular carcinoma: Case report. J Surg Oncol 28:114, 1985.
21. Nesher G, Dollberg L, Zimran A, Hershko C: Hepatosplenic peliosis after danazol and glucocorticoids for ITP. N Engl J Med 312:242, 1985.
22. Hartmann RC, Bruce AC: Fetomaternal outcomes of pregnancy in paroxysmal nocturnal hemoglobinuria. In Bern MM, Frigoletto FD Jr (ed): "Hematologic Disorders in Maternal-Fetal Medicine." New York: Wiley-Liss, Inc., pp 261-282. 1990.
23. Rizzo S, Grignuni G, Gamba G: Fibrinolysis induced by danazol. Blut 53:351, 1986.
24. Murakawa M, Shibuya T, Harada M, et al.: Danazol treatment for paroxysmal nocturnal hemoglobinuria. Jpn J Med 29:417, 1990.
25. Marino C, Cook P: Danazol for lupus thrombocytopenia. Arch Intern Med 145:2251, 1985.
26. Kolodny L, Ahn YS, Horstman L, Brown H: Danazol for refractory prutitus. Am J Hematol 51:112, 1995.
27. Horstman LL, Morgan GP, Ahn YS: CD59 expression on platelets in ITP and PNH. Presented at the 25th Congress of the ISH, La Revista Investigation Clinica, abstract 110. April 1994.
28. Ahn YS, Fernandez LF, Kim CI, et al.: Danazol therapy renders red cells resistant to osmotic lysis. FASEB J 3:157, 1989.
29. Horstman LL, Jy W, Arce M, Ahn YS: Danazol distribution in plasma and cell membranes as related to altered cell properties: Implications for mechanism. Am J Hematol 50:179, 1995.
30. Schreiber AD, Chien P, Tomaski A, Cines DB: Effect of danazol in autoimmune thrombocytopenia. N Engl J Med 316:503, 1987.
31. Mylvaganam R, Ahn YS, Kim CI, Harrington WJ: Immune modulation by danazol in autoimmune thrombocytopenia. Clin Immunol Immunopathol 42:281, 1987.